BeyondSpring Inc. (NASDAQ: BYSI)
$2.29
-0.0500 ( -2.14% ) 21.2K
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It has two reportable segments Plinabulin pipeline and the TPD platform.
Market Data
Open
$2.29
Previous close
$2.34
Volume
21.2K
Market cap
$90.68M
Day range
$2.23 - $2.35
52 week range
$0.65 - $4.00
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 6-k | Quarterly Reports | 1 | Sep 20, 2023 |
| 6-k | Quarterly Reports | 1 | Jul 14, 2023 |